The psychopharmacological and electrophysiological effects of single doses of caffeine in healthy human subjects - PubMed (original) (raw)
Clinical Trial
The psychopharmacological and electrophysiological effects of single doses of caffeine in healthy human subjects
M Bruce et al. Br J Clin Pharmacol. 1986 Jul.
Abstract
The effects of single doses of anhydrous caffeine (250 mg and 500 mg) and placebo on physiological, psychological measures and subjective feelings were studied in a double-blind, cross-over study in nine healthy subjects who had abstained from caffeine-containing beverages for 24 h before each occasion. Caffeine and caffeine metabolites in plasma and urine were assayed. Peak plasma concentrations were observed at 1 to 2 h with an approximate half-life of 5 h. The concentrations of the metabolite 1,7-dimethylxanthine increased during the 5 h. The major urine metabolite was 1-methyluric acid. The EEG showed a dose-related decrease in log 'theta' power and a decrease in log 'alpha' power. Other dose-related effects were an increase in skin conductance level (sweat-gland activity) and self rating of alertness. Ratings of headache and tiredness were decreased by the caffeine. The study illustrates the complexities of studying a drug which is widely taken and which is often associated with withdrawal effects.
Similar articles
- Anxiogenic effects of caffeine in patients with anxiety disorders.
Bruce M, Scott N, Shine P, Lader M. Bruce M, et al. Arch Gen Psychiatry. 1992 Nov;49(11):867-9. doi: 10.1001/archpsyc.1992.01820110031004. Arch Gen Psychiatry. 1992. PMID: 1444724 Clinical Trial. - Pharmacokinetic and -dynamic studies with a new anxiolytic, suriclone, utilizing EEG mapping and psychometry.
Saletu B, Grünberger J, Linzmayer L, Semlitsch HV, Anderer P, Chwatal K. Saletu B, et al. Br J Clin Pharmacol. 1994 Feb;37(2):145-56. doi: 10.1111/j.1365-2125.1994.tb04254.x. Br J Clin Pharmacol. 1994. PMID: 7910470 Free PMC article. Clinical Trial. - [Possibility for assay of psychopharmacological drugs in the example of caffeine and caffeine-free coffee].
Ambrozi L, Birkmayer W. Ambrozi L, et al. Int Z Klin Pharmakol Ther Toxikol. 1970 May;3(2):167-73. Int Z Klin Pharmakol Ther Toxikol. 1970. PMID: 4913084 Clinical Trial. German. No abstract available. - Behavioral effects of caffeine and other methylxanthines on children.
Hughes JR, Hale KL. Hughes JR, et al. Exp Clin Psychopharmacol. 1998 Feb;6(1):87-95. doi: 10.1037//1064-1297.6.1.87. Exp Clin Psychopharmacol. 1998. PMID: 9526149 Review. - Diet-induced mood changes in normal populations.
Leathwood PD, Pollet P. Leathwood PD, et al. J Psychiatr Res. 1982-1983;17(2):147-54. doi: 10.1016/0022-3956(82)90016-4. J Psychiatr Res. 1982. PMID: 6764931 Review.
Cited by
- Pharmacokinetics of Caffeine: A Systematic Analysis of Reported Data for Application in Metabolic Phenotyping and Liver Function Testing.
Grzegorzewski J, Bartsch F, Köller A, König M. Grzegorzewski J, et al. Front Pharmacol. 2022 Feb 25;12:752826. doi: 10.3389/fphar.2021.752826. eCollection 2021. Front Pharmacol. 2022. PMID: 35280254 Free PMC article. Review. - Novel insights on caffeine supplementation, CYP1A2 genotype, physiological responses and exercise performance.
Barreto G, Grecco B, Merola P, Reis CEG, Gualano B, Saunders B. Barreto G, et al. Eur J Appl Physiol. 2021 Mar;121(3):749-769. doi: 10.1007/s00421-020-04571-7. Epub 2021 Jan 5. Eur J Appl Physiol. 2021. PMID: 33403509 Review. - Caffeine as a Tool to Explore Active Cognitive Processing Stages in Two-Choice Tasks.
Barry RJ, Fogarty JS, De Blasio FM. Barry RJ, et al. J Caffeine Adenosine Res. 2020 Jun 1;10(2):71-83. doi: 10.1089/caff.2019.0021. Epub 2020 Jun 4. J Caffeine Adenosine Res. 2020. PMID: 32566904 Free PMC article. - Caffeine Controls Glutamatergic Synaptic Transmission and Pyramidal Neuron Excitability in Human Neocortex.
Kerkhofs A, Xavier AC, da Silva BS, Canas PM, Idema S, Baayen JC, Ferreira SG, Cunha RA, Mansvelder HD. Kerkhofs A, et al. Front Pharmacol. 2018 Jan 4;8:899. doi: 10.3389/fphar.2017.00899. eCollection 2017. Front Pharmacol. 2018. PMID: 29354052 Free PMC article.
References
- Annu Rev Nutr. 1982;2:323-41 - PubMed
- Clin Pharmacol Ther. 1983 Jun;33(6):770-5 - PubMed
- Ann Clin Biochem. 1984 Mar;21 ( Pt 2):120-4 - PubMed
- Clin Pharmacol Ther. 1984 Jul;36(1):133-7 - PubMed
- Am J Orthopsychiatry. 1984 Jul;54(3):375-89 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical